Keith J Kendall - Net Worth and Insider Trading
Keith J Kendall Net Worth
The estimated net worth of Keith J Kendall is at least $2 Million dollars as of 2024-05-14. Keith J Kendall is the CEO and President of Aquestive Therapeutics Inc and owns about 638,964 shares of Aquestive Therapeutics Inc (AQST) stock worth over $2 Million. Details can be seen in Keith J Kendall's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Keith J Kendall has not made any transactions after 2020-06-04 and currently still holds the listed stock(s).
Transaction Summary of Keith J Kendall
Keith J Kendall Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith J Kendall owns 2 companies in total, including Aquestive Therapeutics Inc (AQST) , and Femasys Inc (FEMY) .
Click here to see the complete history of Keith J Kendall’s form 4 insider trades.
Insider Ownership Summary of Keith J Kendall
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
AQST | Aquestive Therapeutics Inc | 2020-06-04 | director & President and CEO |
FEMY | Femasys Inc | 2023-06-14 | director |
Keith J Kendall Latest Holdings Summary
Keith J Kendall currently owns a total of 1 stock. Keith J Kendall owns 638,964 shares of Aquestive Therapeutics Inc (AQST) as of June 4, 2020, with a value of $2 Million.
Latest Holdings of Keith J Kendall
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
AQST | Aquestive Therapeutics Inc | 2020-06-04 | 638,964 | 3.27 | 2,089,412 |
Holding Weightings of Keith J Kendall
Keith J Kendall Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith J Kendall has made a total of 2 transactions in Aquestive Therapeutics Inc (AQST) over the past 5 years, including 1 buys and 1 sells. The most-recent trade in Aquestive Therapeutics Inc is the sale of 50,000 shares on June 4, 2020, which brought Keith J Kendall around $255,500.
Insider Trading History of Keith J Kendall
- 1
Keith J Kendall Trading Performance
GuruFocus tracks the stock performance after each of Keith J Kendall's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Keith J Kendall is 7.94%. GuruFocus also compares Keith J Kendall's trading performance to market benchmark return within the same time period. The performance of stocks bought by Keith J Kendall within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Keith J Kendall's insider trading performs compared to the benchmark.
Performance of Keith J Kendall
Keith J Kendall Ownership Network
Ownership Network List of Keith J Kendall
Ownership Network Relation of Keith J Kendall
Keith J Kendall Owned Company Details
What does Aquestive Therapeutics Inc do?
Who are the key executives at Aquestive Therapeutics Inc?
Keith J Kendall is the director & President and CEO of Aquestive Therapeutics Inc. Other key executives at Aquestive Therapeutics Inc include director & Chief Innovation/Tech Officer Alexander Mark Schobel , Chief Medical Officer Carl N Kraus , and SVP & Research & Development Stephen Wargacki .
Aquestive Therapeutics Inc (AQST) Insider Trades Summary
Over the past 18 months, Keith J Kendall made no insider transaction in Aquestive Therapeutics Inc (AQST). Other recent insider transactions involving Aquestive Therapeutics Inc (AQST) include a net sale of 75,000 shares made by Alexander Mark Schobel ,
In summary, during the past 3 months, insiders sold 75,000 shares of Aquestive Therapeutics Inc (AQST) in total and bought 0 shares, with a net sale of 75,000 shares. During the past 18 months, 75,000 shares of Aquestive Therapeutics Inc (AQST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 75,000 shares.
Aquestive Therapeutics Inc (AQST)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aquestive Therapeutics Inc Insider Transactions
Keith J Kendall Mailing Address
Above is the net worth, insider trading, and ownership report for Keith J Kendall. You might contact Keith J Kendall via mailing address: 30 Technology Drive, Warren Nj 07059.